You just read:

Shire Agrees to FDA Request to Conduct Clinical Trials Investigating the Potential Use of Vyvanse® (lisdexamfetamine dimesylate) in Preschool-Age Children with ADHD

News provided by

Shire plc

12 Jun, 2014, 14:00 BST